Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS 41005 vs Cryotherapy in Hyperkeratotic Actinic Keratosis
NCT01358851Phase 2Completed
- Sponsor
- Almirall
- Start
- Apr 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Actikerall in actinic keratosis (AK), sponsored by Almirall. Primary endpoint: Histological status (AK diagnosis and grade). Started Apr 2011; status: completed.
02
Drugs
Actikerall
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01358851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358851.